Alexza Pharmaceuticals, Inc. (ALXA) Posts Q1 Loss of $1.31/Share
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q1 EPS of ($1.31), $0.86 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $729 thousand versus the consensus estimate of $1 million.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
